Literature DB >> 25318925

Frozen section evaluation of breast carcinoma sentinel lymph nodes: a retrospective review of 1,940 cases.

Justin S Poling1, Theodore N Tsangaris, Pedram Argani, Ashley Cimino-Mathews.   

Abstract

Many sentinel lymph node biopsies (SLNBs) are evaluated intraoperatively by frozen section, which may impact the need for further axillary dissection (AD). However, the need for AD in patients with small metastases has been recently called into question, meaning that frozen SLNB may be unnecessary. Furthermore, frozen section can compromise tissue for further study. At our institution, we grossly evaluate all SLNB and freeze half of the node. Here, we evaluate the frozen SLNB discrepancy rate using this method, focusing on cause of discrepancy and need for further surgery. We reviewed surgical pathology records for all breast cancer resections with frozen section of SLNB examined from 2003 to 2012. For cases with a frozen section discrepancy, we compiled clinicopathologic data. In total, 1,940 cases involved frozen section evaluation of SLNB. In 95 cases (4.9% of total cases, 23.8% of positive node cases), the SLNB was called negative on frozen but positive on final examination (false negatives). The majority of missed metastases are isolated tumor cells or micrometastases. A trend was observed toward fewer patients receiving completion AD after a discrepant frozen SLNB in the later years of the study. The protocol of freezing half of a SLNB is a reasonable method, with results similar to or better than other studies. The main adverse outcome is the need for separate AD; however, additional positive nodes are uncommon. The trend of fewer patients getting additional AD after a discrepant frozen SLNB suggests that clinicians may be using this information differently recently.

Entities:  

Mesh:

Year:  2014        PMID: 25318925      PMCID: PMC4352298          DOI: 10.1007/s10549-014-3161-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  28 in total

1.  The sensitivity and specificity of sentinel lymph node biopsy for breast cancer at Baylor University Medical Center at Dallas: a retrospective review of 488 cases.

Authors:  S Michelle Shiller; Robert Weir; John Pippen; Metin Punar; Daniel Savino
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-04

2.  Frozen section analysis of sentinel lymph nodes in patients with breast cancer does not impair the probability to detect lymph node metastases.

Authors:  Eva V E Madsen; Jan van Dalen; Joost van Gorp; Poultje M P van Oort; Thijs van Dalen
Journal:  Virchows Arch       Date:  2011-11-25       Impact factor: 4.064

Review 3.  Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

Authors:  P L Fitzgibbons; D L Page; D Weaver; A D Thor; D C Allred; G M Clark; S G Ruby; F O'Malley; J F Simpson; J L Connolly; D F Hayes; S B Edge; A Lichter; S J Schnitt
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

Review 4.  Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases.

Authors:  M de Boer; J A A M van Dijck; P Bult; G F Borm; V C G Tjan-Heijnen
Journal:  J Natl Cancer Inst       Date:  2010-02-26       Impact factor: 13.506

5.  Effect of occult metastases on survival in node-negative breast cancer.

Authors:  Donald L Weaver; Takamaru Ashikaga; David N Krag; Joan M Skelly; Stewart J Anderson; Seth P Harlow; Thomas B Julian; Eleftherios P Mamounas; Norman Wolmark
Journal:  N Engl J Med       Date:  2011-01-19       Impact factor: 91.245

6.  Discordance of intraoperative frozen section analysis with definitive histology of sentinel lymph nodes in breast cancer surgery: complementary axillary lymph node dissection is irrelevant for subsequent systemic therapy.

Authors:  D Geertsema; P D Gobardhan; E V E Madsen; M Albregts; J van Gorp; P de Hooge; Th van Dalen
Journal:  Ann Surg Oncol       Date:  2010-04-27       Impact factor: 5.344

7.  Intraoperative touch imprint and frozen section analysis of sentinel lymph nodes after neoadjuvant chemotherapy for breast cancer.

Authors:  Ian K Komenaka; Rozbeh Torabi; Geetha Nair; Lakshmi Jayaram; Chiu-Hsieh Hsu; Marcia E Bouton; Harikrishna Dave; Dan Hobohm
Journal:  Ann Surg       Date:  2010-02       Impact factor: 12.969

8.  Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population.

Authors:  Min Yi; Henry M Kuerer; Elizabeth A Mittendorf; Rosa F Hwang; Abigail S Caudle; Isabelle Bedrosian; Funda Meric-Bernstam; Jamie L Wagner; Kelly K Hunt
Journal:  J Am Coll Surg       Date:  2012-11-02       Impact factor: 6.113

9.  Reliability of frozen section in breast sentinel lymph node examination.

Authors:  Fareed H Barakat; Ibrahim Sulaiman; Maher A Sughayer
Journal:  Breast Cancer       Date:  2012-11-29       Impact factor: 4.239

10.  A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer.

Authors:  Savitri Krishnamurthy; Funda Meric-Bernstam; Anthony Lucci; Rosa F Hwang; Henry M Kuerer; Gildy Babiera; Fredrick C Ames; Barry W Feig; Merrick I Ross; Eva Singletary; Kelly K Hunt; Isabelle Bedrosian
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

View more
  8 in total

Review 1.  Evolution of Frozen Section in Carcinoma Breast: Systematic Review.

Authors:  Manjit Kaur Rana; Amrit Pal Singh Rana; Uttam Sharma; Tushar Singh Barwal; Aklank Jain
Journal:  Int J Breast Cancer       Date:  2022-05-23

2.  Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer?

Authors:  Sung Mi Jung; Jinsun Woo; Jai Min Ryu; Se Kyung Lee; Byung Joo Chae; Jonghan Yu; Seok Won Kim; Seok Jin Nam; Eun Ji Kim; Jeong Eon Lee
Journal:  Ann Surg Treat Res       Date:  2020-10-28       Impact factor: 1.859

3.  Axillary Lymph Node Dissection Can Be Omitted in Breast Cancer Patients With Mastectomy and False-Negative Frozen Section in Sentinel Lymph Node Biopsy.

Authors:  Jing Si; Rong Guo; Huan Pan; Xiang Lu; Zhiqin Guo; Chao Han; Li Xue; Dan Xing; Wanxin Wu; Caiping Chen
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

4.  Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer.

Authors:  Hideo Shigematsu; Shinji Ozaki; Daisuke Yasui; Junichi Zaitsu; Daiki Taniyama; Akihisa Saitou; Kazuya Kuraoka; Hiroyasu Yamashiro; Kiyomi Taniyama
Journal:  Breast Cancer       Date:  2017-11-01       Impact factor: 4.239

5.  Is Routine Intraoperative Frozen Section Analysis of Sentinel Lymph Nodes Necessary in Every Early-Stage Breast Cancer?

Authors:  Bhoowit Lerttiendamrong; Nattanan Treeratanapun; Voranaddha Vacharathit; Kasaya Tantiphlachiva; Phuphat Vongwattanakit; Sopark Manasnayakorn; Mawin Vongsaisuwon
Journal:  Breast Cancer (Dove Med Press)       Date:  2022-09-19

6.  Is the frozen section examination for sentinel lymph node necessary in early breast cancer patients?

Authors:  Kwang Hyun Yoon; Seho Park; Jee Ye Kim; Hyung Seok Park; Seung Il Kim; Young Up Cho; Byeong-Woo Park
Journal:  Ann Surg Treat Res       Date:  2019-07-29       Impact factor: 1.859

7.  Improved detection of sentinel lymph node metastases allows reliable intraoperative identification of patients with extended axillary lymph node involvement in early breast cancer.

Authors:  Cristina L Cotarelo; Annemarie Zschöck-Manus; Marcus Schmidt; Arno Schad; Christoph Brochhausen; Charles James Kirkpatrick; Sonja Thaler
Journal:  Clin Exp Metastasis       Date:  2020-11-29       Impact factor: 5.150

8.  Frozen section evaluation of sentinel lymph nodes in breast carcinoma: a retrospective analysis.

Authors:  Leonardo Russo; Luis Betancourt; Gabriel Romero; Alí Godoy; Laura Bergamo; Rafael Delgado; Ángela Ruiz; Marianna Gutiérrez; Eduardo Salas; Maria Puzzi
Journal:  Ecancermedicalscience       Date:  2017-10-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.